SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001095091-03-000009
Filing Date
2003-01-29
Accepted
2003-01-29 11:47:43
Documents
1
Period of Report
2003-01-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 antigenics12803form3.txt 3 1965
  Complete submission text file 0001095091-03-000009.txt   3923
Mailing Address C/O C G MIDDLETON 2500 BROWN & WILLIAMSON TOWER LOUISVILLE KY 40202
Business Address C/O C G MIDDLETON 2500 BROWN & WILLIAMSON TOWER LOUISVILLE KY 40202
KELLEY BRAD M (Reporting) CIK: 0001095091 (see all company filings)

 

Mailing Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111 2123324774
ANTIGENICS INC /DE/ (Subject) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-29089 | Film No.: 03529257
SIC: 2836 Biological Products, (No Diagnostic Substances)